Soleus Capital Management as of June 30, 2020
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 60 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zymeworks Put Option | 15.4 | $27M | 749k | 36.07 | |
| Essa Pharma Com New (EPIX) | 7.4 | $13M | 2.1M | 6.20 | |
| Iveric Bio | 4.7 | $8.3M | 1.6M | 5.10 | |
| Astrazeneca Sponsored Adr (AZN) | 4.1 | $7.2M | 136k | 52.89 | |
| Prothena Corp SHS (PRTA) | 4.0 | $7.1M | 675k | 10.46 | |
| Quidel Corporation | 3.9 | $6.9M | 31k | 223.72 | |
| Eiger Biopharmaceuticals | 3.4 | $6.0M | 620k | 9.60 | |
| Alexion Pharmaceuticals | 3.2 | $5.7M | 51k | 112.23 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $5.5M | 35k | 160.32 | |
| Iradimed (IRMD) | 2.8 | $4.9M | 212k | 23.21 | |
| Adverum Biotechnologies | 2.6 | $4.6M | 219k | 20.88 | |
| Zynex (ZYXI) | 2.5 | $4.4M | 177k | 24.87 | |
| Immunomedics | 2.4 | $4.2M | 119k | 35.44 | |
| Dex (DXCM) | 2.2 | $3.9M | 9.6k | 405.34 | |
| Aeglea Biotherapeutics | 2.0 | $3.4M | 370k | 9.25 | |
| Eli Lilly & Co. (LLY) | 1.9 | $3.4M | 21k | 164.13 | |
| Novocure Ord Shs (NVCR) | 1.9 | $3.3M | 56k | 59.29 | |
| Vericel (VCEL) | 1.9 | $3.3M | 239k | 13.82 | |
| Inari Medical Ord (NARI) | 1.8 | $3.2M | 66k | 48.44 | |
| Xenon Pharmaceuticals (XENE) | 1.8 | $3.1M | 251k | 12.54 | |
| Abbvie (ABBV) | 1.6 | $2.8M | 29k | 98.17 | |
| Misonix | 1.5 | $2.7M | 196k | 13.57 | |
| Itamar Med Sponsored Ads | 1.5 | $2.6M | 141k | 18.59 | |
| OraSure Technologies (OSUR) | 1.5 | $2.6M | 223k | 11.63 | |
| Humana (HUM) | 1.5 | $2.6M | 6.6k | 387.73 | |
| Nevro (NVRO) | 1.3 | $2.2M | 19k | 119.47 | |
| Ionis Pharmaceuticals (IONS) | 1.2 | $2.1M | 36k | 58.96 | |
| Amicus Therapeutics (FOLD) | 1.1 | $1.9M | 127k | 15.07 | |
| SurModics (SRDX) | 1.1 | $1.9M | 44k | 43.23 | |
| Axonics Modulation Technolog (AXNX) | 1.0 | $1.7M | 49k | 35.10 | |
| Horizon Therapeutics Pub SHS | 0.9 | $1.6M | 30k | 55.57 | |
| Rafael Hldgs Com Cl B (RFL) | 0.9 | $1.5M | 105k | 14.37 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.7 | $1.3M | 17k | 73.49 | |
| Staar Surgical Com Par $0.01 (STAA) | 0.7 | $1.3M | 20k | 61.53 | |
| Silk Road Medical Inc Common (SILK) | 0.7 | $1.2M | 28k | 41.86 | |
| Fate Therapeutics (FATE) | 0.6 | $1.1M | 33k | 34.30 | |
| Kadmon Hldgs | 0.6 | $1.0M | 201k | 5.12 | |
| Biohaven Pharmaceutical Holding | 0.6 | $1.0M | 14k | 73.07 | |
| Constellation Pharmceticls I | 0.6 | $1.0M | 33k | 30.03 | |
| Gossamer Bio Note 5.000% 6/0 (Principal) | 0.6 | $1.0M | 1.0M | 1.00 | |
| Vapotherm | 0.5 | $889k | 22k | 40.97 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.5 | $887k | 100k | 8.87 | |
| Provention Bio | 0.5 | $845k | 60k | 14.11 | |
| Insulet Corporation (PODD) | 0.4 | $777k | 4.0k | 194.25 | |
| Masimo Corporation (MASI) | 0.4 | $775k | 3.4k | 227.94 | |
| Axogen (AXGN) | 0.4 | $742k | 80k | 9.23 | |
| Revance Therapeutics (RVNC) | 0.4 | $695k | 29k | 24.41 | |
| Lyra Therapeutics (LYRA) | 0.4 | $687k | 61k | 11.32 | |
| Pacira Pharmaceuticals (PCRX) | 0.4 | $640k | 12k | 52.46 | |
| Antares Pharma | 0.4 | $629k | 229k | 2.75 | |
| Biogen Idec (BIIB) | 0.4 | $615k | 2.3k | 267.39 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $577k | 12k | 50.17 | |
| Castle Biosciences (CSTL) | 0.3 | $565k | 15k | 37.67 | |
| Harpoon Therapeutics | 0.3 | $512k | 31k | 16.58 | |
| Inspire Med Sys (INSP) | 0.3 | $488k | 5.6k | 87.02 | |
| Rapt Therapeutics (RAPT) | 0.2 | $438k | 15k | 29.01 | |
| Larimar Therapeutics (LRMR) | 0.2 | $400k | 31k | 12.83 | |
| Relmada Therapeutics (RLMD) | 0.2 | $308k | 6.9k | 44.64 | |
| Arvinas Ord (ARVN) | 0.1 | $201k | 6.0k | 33.50 | |
| Insmed Note 1.750% 1/1 (Principal) | 0.1 | $174k | 180k | 0.97 |
